Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4

Mehriar Shokri ¹, Bahador Bagheri ², Alireza Garjani ³, Bahram Sohrabi ¹ * , Afshin Habibzadeh ⁴, Babak Kazemi ¹, Ali Akbar Movassaghpour ⁵

Cited by CrossRef: 7

1- Brenner A, Andersson Tvedt T, Bruserud Ø. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells. Molecules. 2016;21(11):1512 [Crossref]

2- Li Y, Guo J, Yu H, Liu X, Zhou J, Chu X, Xu Q, Sun T, Peng L, Yang X, Tang X. Valsartan prevented neointimal hyperplasia and inhibited SRSF1 expression and the TLR4–iNOS–ERK–AT1 receptor pathway in the balloon-injured rat aorta. Physiol Res. 2021;:533 [Crossref]

3- Bagheri B, Khatibiyan Feyzabadi Z, Nouri A, Azadfallah A, Mahdizade Ari M, Hemmati M, Darban M, Alavi Toosi P, Banihashemian S, Trentini A. Atherosclerosis and Toll-Like Receptor4 (TLR4), Lectin-Like Oxidized Low-Density Lipoprotein-1 (LOX-1), and Proprotein Convertase Subtilisin/Kexin Type9 (PCSK9). Mediators of Inflammation. 2024;2024:1 [Crossref]